Randomized, double-blind, comparative clinical trial on the efficacy and safety of intralesional sodium stibogluconate and intralesional 7% hypertonic sodium chloride against cutaneous leishmaniasis caused by L. donovani

References

• Castellani A. Leishmania donovani in Ceylon. J Trop Med. 1904;10:262.
   Google Scholar
• Nawaratna SKS, Weilgama DJ, Wijekoon CJ, Dissanayaka M, Rajapaksha K. Cutaneous leishmaniasis, Sri Lanka. Emerging Infect Dis. 2007;13:1068–1070.
   PubMed Web of Science ®Google Scholar
• Rajapaksa US, Ihalamulla RL, Udagedera C, Karunaweera ND. Cutaneous leishmaniasis in Southern Sri Lanka. Trans R Soc Trop Med Hyg. 2007;101:799–803.
   PubMed Web of Science ®Google Scholar
• Karunaweera ND, Pratlong F, Siriwardane HVYD, Ihalamulla RL, Dejet JP. Sri Lanka cutaneous leishmaniasis is caused by Leishmania donovani zymodeme MON-37. Trans R Soc Trop Med Hyg. 2003;97:380–381.
   PubMed Web of Science ®Google Scholar
• Siriwardana HVYD, Noyes HA, Beeching NJ, Chance ML, Karunaweera ND, Bates PA. Leishmania donovani and cutaneous leishmaniasis, Sri Lanka. Emerging Infect Dis. 2007;13:476–478.
   PubMed Web of Science ®Google Scholar
• Athkorala DN, Seneviratne JKK, Ihalamulla RL, Premaratne UN. Locally acquired cutaneous leishmaniasis in Sri Lanka. J Trop Med Hyg. 1992;95:432–433.
   PubMedGoogle Scholar
• Rajapaksa US, Ihalamulla RL, Karunaweera ND. First report of mucosal tissue localization of leishmaniasis in Sri Lanka. Ceylon Med J. 2005;50(2):90–91.
   PubMedGoogle Scholar
• Abeygunasekara PH, Costa YJ, Seneviratne N, Ratnatunga N, Wijesundara MS. Locally acquired visceral leishmaniasis in Sri Lanka. Ceylon Med J. 2007;52(1):30–31.
   PubMedGoogle Scholar
• Sharquie KE. A new intralesional therapy of cutaneous leishmaniasis with hypertonic sodium chloride solution. J Dermatol. 1995;22(10):732–737.
   PubMedGoogle Scholar
• Sharquie KE, Najim RA, Farjou IB. A comparative controlled trial of intralesionally administered zinc sulphate, hypertonic sodium chloride and pentavalent antimony compound against acute cutaneous leishmaniasis. Clin Exp Dermatol. 1997;22(4):169–173.
   PubMedGoogle Scholar
• World Health Organization. The leishmaniasis: Report of a WHO expert committee. Technical Report Series. WHO 701; 1984.
   Google Scholar
• Faris RM, Jarallah JS, Khoja TA, al-Yamani MJ. Intralesional treatment of cutaneous leishmaniasis with sodium stibogluconate antimony. Int J Dermatol. 1993;32(8):610–612.
   PubMedGoogle Scholar
• Sharquie KE, Al-Talib KK, Chu AC. Intralesional therapy of cutaneous leishmaniasis with sodium stibogluconate antimony. Br J Dermatol. 1988;119(1):53–57.
   PubMedGoogle Scholar
• Tallab TM, Bahamdam KA, Mirdad S, Johargi H, Mourad MM, Ibrahim K, Cutaneous leishmaniasis: Schedules for intralesional treatment with sodium stibogluconate. Int J Dermatol. 1996;35(8):594–597.
   PubMedGoogle Scholar
• Solomon M, Baum S, Barzilai A, Pavlotsky F, Trau H, Schwartz E. Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate. J Eur Acad Dermatol Venereol. 2009;23(10):1189–1192. Epub 2009 Feb 24.
   PubMed Web of Science ®Google Scholar
• Negi AK, Sharma NL, Mahajan VK, Ranjan N, Kanga AK. Comparative efficacy of intralesional sodium stibogluconate (SSG) alone and its combination with intramuscular SSG to treat localized cutaneous leishmaniasis: Results of a pilot study. Indian J Dermatol Venereol Leprol. 2007;73(4):280.
   PubMedGoogle Scholar
• Herwaldt BL, Berman JD. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg. 1992;46(3):296–306.
   PubMedGoogle Scholar
• Mosleh IM, Geith E, Natsheh L, Schonian G, Abotteen N, Kharabsheh S. Efficacy of weekly cryotherapy regimen to treat Leishmania major cutaneous leishmaniasis. J Am Acad Dermatol. 2008;58:617–624.
   PubMed Web of Science ®Google Scholar
• Layegh P, Pezeshkpoor F, Soruri AH, Naviafar P, Moghiman T. Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children. Am J Trop Med Hyg. 2009;80(2):172–175.
   PubMedGoogle Scholar
• Asilian A, Sadeghinia A, Faghihi G, Momeni A, Amini Harandi A. The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis. Ann Trop Med Parasitol. 2003;97(5):493–498.
   PubMedGoogle Scholar
• Nawaratna SS, Weilgama DJ, Rajapaksha K. Cutaneous leishmaniasis in Sri Lanka: A study of possible animal reservoirs. Int J Infect Dis. 2009;13(4):513–517. Epub 2008 Dec 17.
   Google Scholar
• Surendran SN, Kajatheepan A, Ramasamy R. Socio-environmental factors and sandfly prevalence in Delft Island, Sri Lanka: Implications for leishmaniasis vector control. J Vect Borne Dis. 2007;44:65–68.
   PubMedGoogle Scholar
• Al-Jawabreh A, Nasereddin A. Leishmaniasis recidivans in a Palestinian Bedouin child. Skinmed. 2007;6(5):250–252.
   PubMedGoogle Scholar
• Griffiths WAD, Croft SL. Cutaneous leishmaniasis. Postgraduate Doctor Middle East. 1980;3:338–340.
   Google Scholar
• Najim RA, Sharquie KE, Al-Zubaidy SAA. Possible mechanisms of action of the compounds injected intralesionally in the treatment of cutaneous leishmaniasis, in addition to their direct effects on the parasites. Ann Trop Med Parasitol. 2006;100(1):33–38.
   PubMedGoogle Scholar